NCT04088851Active, not recruiting
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
"Non-invasive Measurement of Hepatic Substrate Flux Rates in People with Diabetes Mellitus Type 2"
Source: ClinicalTrials.gov · Last updated 13 Jan 2025
Brief summary (registry, in English)
Investigation of the effects of redox shuttle inhibition by metformin on gluconeogenic flux rates of lactate and glycerol in humans with type 2 diabetes
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- First submitted
- 11 Sept 2019
- Start date
- 11 Sept 2019
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- German Diabetes Center
- Diseases
- Type 2 diabetes
- NCT number
- NCT04088851
What you commit to
- Study type: Interventional
- Planned participants: 23
- From 11 Sept 2019 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- diabetes types other than type 2 diabetes (ADA criteria)
- clinically relevant angiopathy, restrictive or obstructive lung diseases
- other acute or chronic diseases including wounds and the use of pharmacological agents known to affect insulin sensitivity, lipid metabolism or immunological function.
Lab values
- uncontrolled hyperglycaemia (\>340 mg/dl)
Other
- thiazolidinedione use during the preceding 6 months
Who the study is looking for
- type 2 diabetes (duration \<7 years),
- age (18-75 years)
- BMI \<40 kg/m2
- HbA1c 6-15%
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| German Diabetes Center Coordinator of this site? Confirm its status | Düsseldorf | Germany | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.